Update on the role of pharmaceutical-grade chondroitin sulfate (CS) in the symptomatic management of knee osteoarthritis. 

In this literature review from 2019, the authors summarized the most recent findings on the efficacy and safety of CS in OA.  Based on the results of studies presenting a low risk of bias, the most recent meta-analysis shows that only the pharmaceutical-grade CS may be considered as an appropriate background treatment for the management of knee OA. 

References:

Honvo G, Bruyère O, Reginster JY. Update on the role of pharmaceutical-grade chondroitin sulfate in the symptomatic management of knee osteoarthritis. Aging Clin Exp Res. 2019;31(8):1163-1167. doi:10.1007/s40520-019-01253-z https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661017/ 

INGREDIENTS WITH THIS RESEARCH​

Let’s keep in touch

Don’t worry we only send updates monthly on offers, product changes, and new opportunities for you.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Scroll to Top

Due to the potential Canada Post strike, we recommend not using Canada Post to return DNA samples, as delays or lost packages may occur. To ensure safe and timely delivery, please use a reliable courier such as UPS or Purolator until the strike is resolved to send back your sample.

If you do not want to incur additional shipping charges to return your sample via courier, we suggest you wait until the strike is over and use the pre-paid postage Canada Post envelope provided in your kit.

Close

*Cannot be combined with any other offers. Excludes MyBlueprint™, Lactoferrin products and subscription orders.

Close
×
Why Choose to Subscribe and Save?
  • Automatically re-order your favorite products on your schedule.
  • Easily change the products or shipping date for your upcoming Scheduled Orders.
  • If you decide a subscription is not for you, it can be cancelled after 2 renewals.

Autoship powered by